India Pharma 2026 Conference to Promote India as Global Life-Sciences Innovation Hub

The 9th India Pharma 2026 conference, organized by the Department of Pharmaceuticals, FICCI, and IPA, will be held on April 13-14. Inaugurated by Union Ministers JP Nadda and Anupriya Patel, the event aims to transition India's pharmaceutical sector from a volume-driven model to a value- and innovation-led global powerhouse. With the theme 'Discover in India: Leapfrogging Life-Sciences Innovation,' it will foster international collaboration, highlight R&D, and strengthen global health systems, featuring policymakers and industry experts.

The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, in collaboration with FICCI and the Indian Pharmaceutical Alliance (IPA), is organizing the 9th edition of India Pharma 2026 on April 13-14. This significant event aims to propel India's pharmaceutical industry towards becoming a global innovation hub. The conference will be inaugurated by JP Nadda, Minister of Chemicals and Fertilizers, and Anupriya Patel, Union Minister of State for Chemicals and Fertilizers, underscoring its national importance. Serving as a crucial platform for sectoral growth and international collaboration, India Pharma 2026 will focus on leveraging India's robust pharmaceutical capabilities, advancing research and development (R&D), and enhancing the resilience of global supply chains. The chosen theme, 'Discover in India: Leapfrogging Life-Sciences Innovation,' emphasizes the transformative potential of life sciences in improving healthcare accessibility, stimulating economic development, and bolstering global health infrastructure. The ministry highlights India's pivotal role in supplying affordable, high-quality medicines worldwide. Building on this foundation, the conference seeks to shift the sector's paradigm from a volume-centric approach to one driven by value and innovation, positioning India as a global pharmaceutical powerhouse. The event will gather a distinguished array of participants, including key policymakers such as Manoj Joshi, Punya Salila Srivastava, and Prof. Vinod K. Paul, alongside eminent domain experts like Dr. Renu Swarup and Dr. Shivkumar Kalyanaraman. Featuring six plenary sessions and a dedicated 'Start-up Showcase,' India Pharma 2026 promises comprehensive discussions and networking opportunities for all stakeholders.